Clinical Trials
Clinical trials are research studies that are conducted in human subjects to evaluate new ways to prevent, detect, treat, or manage cancer or other diseases. Through clinical trials, researchers are able to determine whether or not new treatments, such as drugs, procedures, or medical devices, are safe and effective, and whether or not they work better than current treatments. Learning more about clinical trials can help you make an informed decision about whether or not to participate in one as part of your colorectal cancer treatment.
Possible Benefits of Participating in a Clinical Trial
If you have a disease such as colorectal cancer, there could be personal benefits such as:
A potential early access to a new treatment with positive results; the treatment may cure or control your condition or improve your quality of life; you may receive more expert medical care from the research teams involved in the clinical trial.
In addition, participating in a clinical trial can help others by advancing medical research.
Possible Benefits of Participating in a Clinical Trial
If you have a disease such as colorectal cancer, there could be personal benefits such as:
A potential early access to a new treatment with positive results; the treatment may cure or control your condition or improve your quality of life; you may receive more expert medical care from the research teams involved in the clinical trial.
In addition, participating in a clinical trial can help others by advancing medical research.
Possible Risks of Participating in a Clinical Trial
Because clinical trials often compare a new drug to an approved drug or combination of drugs that are part of the current standard of care, you may not always receive a new treatment. Even if you get a new drug, it may not help you. It may be less effective than the standard of care. As with any treatment, there is the risk of serious short- or long-term side effects.
Reducing Your Risk
Before you participate in a clinical trial, it is very important that you understand what is involved and give your informed consent. Talk to your doctor to best understand the risks and benefits so you can make an informed choice about participating.
Types of Clinical Trials
This type of trial looks at whether a particular treatment can help prevent cancer. These trials can be conducted in the general population or in people who have a higher than normal risk of developing a certain type of cancer, such as those with a family history of the disease.
Screening trials involve testing people for early signs of cancer before they have symptoms. These trials can be done in the general population or in a group of people who are at higher than normal risk of developing cancer. Screening trials may look at the effectiveness of a new screening test compared to standard tests.
Treatment trials are conducted in stages or phases. In trials that compare two or more treatments, participants are randomly assigned to a specific treatment group. Randomized trials give researchers the most reliable information about how well a new treatment works.
Types of Clinical Trials
Finding the Right Clinical Trial
Talk to your healthcare team to find out if participating in a clinical trial is right for you. You can also access the clinical trial databases below or contact a clinical trial navigator to learn more and find trials specific to your needs and location.
Clinical Trial Navigator Services in Canada
Canadian Cancer Clinical Trials Network
Clinical Trials Navigator provided by the Windsor Regional Hospital
The Clinical Trials Navigator is designed to help cancer patients search for and connect with clinical trials for which they may be eligible. The patient begins by completing an informed consent form, or their physician can complete a referral form. The patient is connected to the Clinical Trials Navigator, which helps them search for all eligible trials.
Contact the Clinical Trials Navigator at clinicaltrialsnavigator@wrh.on.ca;
P: (519) 253-3191 ext. 58583
Additional Clinical Trials Resources
Phase 3 Trial Finds that a Structured Exercise Program Significantly Improves Survival and Reduces Recurrence in Colorectal Cancer Patients
A randomized phase 3 trial (CHALLENGE, CO.21) conducted by the Canadian Cancer Trials Group found that a 3-year structured exercise program following surgery and chemotherapy significantly improved outcomes for patients with stage III and high-risk...
New Treatment Combination Lowers Risk of Death by Half for Patients with BRAFV600E-Mutated Metastatic Colorectal Cancer
New results from the Phase 3 BREAKWATER clinical trial show that a combination treatment including BRAFTOVI® (encorafenib), cetuximab, and chemotherapy significantly improves survival for patients with metastatic colorectal cancer that has a specific genetic change...
Improving Safety in Polyp Removal: The Closure Trial
Colorectal cancer often starts as a small polyp that slowly grows until it becomes cancerous. Research indicates that once a polyp reaches around 20mm in size, it can rapidly progress to cancer. Removing these larger...
The ABLATION Trial: Evaluating New Techniques for Safer, More Effective Removal
Colorectal cancer often begins as a small polyp in the colon that slowly grows until it becomes cancerous. Research shows that once a polyp reaches about 20mm in size, it can quickly progress to cancer....
United for Action: Avitia and Colorectal Cancer Canada Advance Patient Outcomes
Mar 2025 United for Action: Avitia and Colorectal Cancer Canada Advance Patient Outcomes While colorectal cancer remains one of the most pressing health challenges, innovation and collaboration are changing the landscape in early detection and...
Aspirin Lowers Colorectal Cancer Recurrence Risk in Patients with P13K Mutations
March 2025 A phase 3 trial presented at the 2025 Gastrointestinal Cancers Symposium showed that three years of aspirin use significantly reduced the risk of recurrence in colorectal cancer patients with PIK3CA mutations. What is...